HIP
AMRX icon

HUB Investment Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

HUB Investment Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Buy
16,780
+736
+5% +$10.1K 0.01% 1013
2026
Q1 		$199K Hold
16,044
– – ﹤0.01% 1003
2025
Q4 		$202K Hold
16,044
– – 0.01% 845
2025
Q3 		$161K Hold
16,044
– – 0.01% 729
2025
Q2 		$130K Hold
16,044
– – ﹤0.01% 662
2025
Q1 		$134K Hold
16,044
– – 0.01% 572
2024
Q4 		$127K Hold
16,044
– – 0.01% 529
2024
Q3 		$133K Buy
16,044
+1,044
+7% +$8.16K 0.01% 499
2024
Q2 		$95.3K Hold
15,000
– – ﹤0.01% 474
2024
Q1 		$90.9K Hold
15,000
– – 0.01% 463
2023
Q4 		$91K Buy
+15,000
New +$66.8K 0.01% 392

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

HUB Investment Partners's AMRX Position: Q2 2026 in Review

HUB Investment Partners increased its Amneal Pharmaceuticals (AMRX) stake by 4.6% in Q2 2026, buying an estimated $10.1K and bringing the position to 16,780 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #1013.

HUB Investment Partners first reported a position in AMRX in Q4 2023 and has held it in 11 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • HUB Investment Partners held 16,780 shares of Amneal Pharmaceuticals worth $290K as of Q2 2026.
  • HUB Investment Partners bought 736 Amneal Pharmaceuticals shares in Q2 2026, an estimated $10.1K.
  • Amneal Pharmaceuticals made up 0.01% of HUB Investment Partners's portfolio in Q2 2026, its #1013 holding.
  • HUB Investment Partners first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.